Latest News
OptiBiotix Health revenues soar in Q1
Life sciences group OptiBiotix Health saw revenues soar in the first quarter of its trading year thanks to its partnership agreements.
Norman Broadbent sees positive momentum carry over into 2020
Professional services firm Norman Broadbent said on Monday that the positive momentum seen last year had carried over into the first four months of 2020.
Europe open: Stocks rally as Merkel and Macron prepare EU-wide initiative
Stocks rallied at the start of the week as Germany and France moved to organise a Europe-wide response to the pandemic and the head of the US Central bank sounded a warily confident note on the outlook.
Ted Baker makes David Wolffe permanent CFO
Ted Baker has appointed David Wolffe as chief financial officer, the job he has held on an interim basis since the start of 2020.
Gold hits fresh highs as economic fears mount
Gold prices have soared to a near-eight year high as concerns about the economic fallout from the Covid-19 pandemic mount.
Altyn clears important hurdle in extending Sekisovskoye to 2030
Altyn said on Monday that it has achieved an “important milestone” in the extension of its mining contract at Sekisovskoye to 2030.
Peel Hunt initiates Stagecoach at 'hold'
Peel Hunt initiated coverage on shares of transport operator Stagecoach at ‘hold’ with a 64p price target.
Short-selling bans lifted by six EU countries
France and Spain are among six EU countries lifting bans on short selling of shares that they introduced during high market volatility caused by the Covid-19 crisis.
Hiscox customers ready to launch Covid-19 case
A group of companies seeking £40m of payouts from Hiscox under business interruption policies has received the green light from lawyers and funders to start legal action against the insurer.
Intu seeking standstill with creditors until end 2021
Shopping centre owner Intu Properties said on Monday that it is seeking standstill agreements with its creditors as it warned it could breach its covenants amid uncertainty over the impact of the Covid-19 outbreak.
Vast Resources raises £0.9m via placing and subscription
Vast Resources has raised a total of £0. 9m before costs, it announced on Monday, through a placing and a subscription of 600,944,440 ordinary shares at a price of 0. 15p each.
Conroy Gold upbeat after identifying new features at Clontibret
Conroy Gold and Natural Resources announced on Monday that the interpretation of a ground geophysical survey, conducted by Golder Associates before the outbreak of Covid-19 on the Clontibret gold deposit, has identified new geological and structural features.
London open: Miners, energy shares pace gains as stocks rally
London stocks rose in early trade on Monday, boosted by strength in the energy and mining sectors, amid optimism over lockdown easing and after the US Federal Reserve chair hinted at more ammunition to combat the fallout from the Covid-19 pandemic.
LXi REIT declares Q1 dividend after NAV return rises
LXi REIT said it expected to declare a first quarter dividend as the commercial property investor reported an increased annual return and said it was in talks to recover unpaid rent.
Catenae Innovations trials new Cov-ID app
Digital media and technology group Catenae Innovation said on Monday that it had begun trialling and finalisation of its new Cov-ID app.
Jim North appointed acting CEO of Ferrexpo
Ferrexpo announced the appointment of James ‘Jim’ North as its acting chief executive officer on Monday, effective from the end of its annual general meeting, to be held on 28 May.
Centamin sticks to guidance as rising gold price boosts profit
Centamin reiterated its financial guidance for the current year after the rising price of gold helped push the gold miner's annual profit up by 13%.
Vodafone agrees deal to bring Oppo devices to Europe
Vodafone announced a partnership agreement with Chinese smartphone brand Oppo on Monday, which will see a range of devices brought to the carrier’s European markets from this month.
GlaxoSmithKline hails HIV treatment breakthrough
GlaxoSmithKline said on Monday that ViiV Healthcare, in which it owns a majority stake, is ending a study early after finding that its long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral pre-exposure prophylaxis (PrEP) in preventing HIV transmission.
AstraZeneca clears regulatory hurdles for Enhertu and Bevespi Aerosphere
AstraZeneca, alongside its partner Daiichi Sankyo, announced on Monday that ‘Enhertu’, or trastuzumab deruxtecan, has been granted breakthrough therapy designation in the United States.